Cellular and molecular mechanisms controlling sepsis-induced immunoparalyses state

控制脓毒症诱导的免疫麻痹状态的细胞和分子机制

• 批准号: 10557190
• 负责人: VLADIMIR P BADOVINAC
• 金额: $ 38.52万
• 依托单位: UNIVERSITY OF IOWA
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-02-01 至 2025-01-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10557190
• 关键词: Address; American; Area; Autoimmune Responses; CD8-Positive T-Lymphocytes; Cell Survival; Cells; Chronic; Clinical; Development; Experimental Models; Functional disorder; Goals; Human; Immune; Immune response; Immune system; Immunosuppression; Individual; Infection; Inflammatory; Life; Lymphocyte; Lymphocyte Count; Lymphopenia; Maintenance; Memory; Molecular; Mus; Organ; Pathway interactions; Patients; Phase; Population; Predisposition; Public Health; Research; Secondary to; Sepsis; Survivors; T cell response; Vaccines; Viral; cytokine release syndrome; mortality; pathogenic bacteria; pathogenic virus; secondary infection; septic; tumor

Project Summary/Abstract Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. It represents a significant public health burden striking 1.7 million American annually (with 20-25% mortality). In general, early stages of sepsis are characterized by a potentially detrimental hyperinflammatory state. However, patients who survive the cytokine storm phase of sepsis enter a state of immunoparalysis defined by enhanced susceptibility to infection, viral reactivation, and mortality years after the septic insult. Sepsis-induced lymphopenia reduces the number of immune cells and influences the function of remaining/surviving cells. Yet, the sepsis-induced lymphopenia is transient while the prolonged immunoparalysis (or immunosuppression) that develops (even after lymphocyte numbers normalize) is now considered a leading reason for the extended period of increased susceptibility to bacterial and viral pathogens normally handled by the immune system in healthy individuals. Therefore, our long-term goal is to precisely determine, on cellular and molecular levels, sepsis-induced changes in various lymphocyte populations that support and define the chronic state of immunoparalysis and inability of immune cells to exert their effector functions properly. We identified four interconnected areas of research that we will pursue: a) Explore molecular mechanisms that govern long-term maintenance and function of infection-or vaccine-induced protective memory CD8 T cell responses after sepsis; b) Define the cellular basis of increased susceptibility to tumor development and decreased ability to evoke autoimmune responses in sepsis survivors; c) Develop new experimental models of sepsis research; d) Investigate the interplay between clinical (human) and experimental (mouse) research to elucidate mechanisms and pathways that control sepsis-induced immunoparalysis state. Addressing these key gaps in our understanding of sepsis-induced immunoparalysis will ultimately uncover new targets that can be used to develop better and more efficient treatments of sepsis survivors.

项目总结/文摘